Eko Foundation Analysis Software with Transformers (EFAST) vs OMRON VitalSight
AI Verdict
Choose Eko Foundation Analysis Software with Transformers (EFAST) if…
Choose EFAST if your primary need is real-time, AI-powered cardiac screening during routine physical exams to quickly identify potential structural heart murmurs or atrial fibrillation. This tool is ideal for clinicians seeking immediate, actionable insights at the point of care, enhancing early detection and referral for further cardiac evaluation.
View Eko Foundation Analysis Software with Transformers (EFAST) →Choose OMRON VitalSight if…
Choose OMRON VitalSight if your focus is on comprehensive, long-term remote patient monitoring for hypertension management. This service is best suited for physicians looking to securely track patient blood pressure trends from home, receive automatic alerts for out-of-range readings, and streamline data integration directly into their EHR for improved patient outcomes.
View OMRON VitalSight →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Foundation Analysis Software with Transformers (EFAST) | OMRON VitalSight |
|---|---|---|
| Pricing | Subscription-based, contact for details | Reimbursement-based |
| Deployment | Unknown | Cloud-based (physician dashboard) with at-home patient devices. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Foundation Analysis Software with Transformers (EFAST)EFAST integrates real-time AI analysis directly into the clinician's auscultation workflow, providing immediate, actionable insights during a routine exam. Its features like enhanced audio, waveform visualization, and guided exams are designed to augment a core clinical skill, making it highly usable within the point-of-care diagnostic process.
Clinical Value
Eko Foundation Analysis Software with Transformers (EFAST)EFAST offers high sensitivity and specificity for detecting critical cardiac conditions like structural murmurs and atrial fibrillation, providing immediate diagnostic insights that can lead to earlier intervention. While VitalSight provides valuable chronic disease management, EFAST's ability to augment real-time diagnosis of potentially life-threatening conditions during a standard physical exam offers a more direct and impactful clinical value.
Pricing & Value
OMRON VitalSightOMRON VitalSight's reimbursement-based model, with generally little to no cost for patients (depending on coverage) and no setup or device costs for physicians, presents a highly attractive financial proposition. In contrast, EFAST requires a subscription and involves hardware costs for its advanced stethoscope technology.
Enterprise Readiness
TieBoth EFAST and VitalSight are FDA-cleared, HIPAA compliant, and have Business Associate Agreements (BAAs) in place, demonstrating strong regulatory and security adherence. Both also offer EMR/EHR integration and are cloud-based, indicating comparable readiness for enterprise-level deployment.
Innovation
Eko Foundation Analysis Software with Transformers (EFAST)EFAST utilizes advanced AI, specifically 'Transformers,' for real-time, high-accuracy detection of complex cardiac conditions during auscultation, representing a significant technological advancement in diagnostic augmentation. While VitalSight offers innovative aspects in remote patient monitoring logistics (e.g., data hub without Wi-Fi), EFAST's core AI application to a traditional clinical exam is more cutting-edge.
Support & Docs
Eko Foundation Analysis Software with Transformers (EFAST)Eko Health provides a comprehensive online Help Center with specific user manuals (IFUs) for EFAST, FAQs, and how-to videos, alongside options to contact support and schedule calls. While OMRON also offers user guides and customer service, Eko's structured and varied support resources appear more extensive and readily accessible for users.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Foundation Analysis Software with Transformers (EFAST) | OMRON VitalSight |
|---|---|---|
| Name | Eko Foundation Analysis Software with Transformers (EFAST) | OMRON VitalSight |
| Company | Eko Health | OMRON Healthcare |
| Description | EFAST by Eko Health is an advanced, FDA-cleared AI model that assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation, providing real-time, actionable cardiac insights during routine exams. | OMRON VitalSight is a remote patient monitoring service for US physicians, offering connected blood pressure monitors and data hubs that securely integrate with EHRs to manage hypertension and improve patient outcomes. |
| Key Functionality | AI-powered structural murmur detection (93% sensitivity, 91% specificity); AI-powered atrial fibrillation (AFib) detection (95% sensitivity, 94% specificity); Real-time AI analysis during auscultation. | Remote blood pressure monitoring; Connected blood pressure monitor and data hub kit; Automatic notifications for out-of-range readings. |
| Specialties | Cardiology, Family Medicine, Internal Medicine | Cardiology, Internal Medicine, Nephrology |
Videos
Demos, reviews, and walkthroughs featuring Eko Foundation Analysis Software with Transformers (EFAST) and OMRON VitalSight.
Frequently Asked Questions
More Comparisons
More matchups featuring Eko Foundation Analysis Software with Transformers (EFAST) or OMRON VitalSight
- OMRON VitalSight vs Cardiomo
- OMRON VitalSight vs EchoNext
- OMRON VitalSight vs Sleepiz One+
- Eko Foundation Analysis Software with Transformers (EFAST) vs Sleepiz One+
- Eko Foundation Analysis Software with Transformers (EFAST) vs EchoNext
- Eko Foundation Analysis Software with Transformers (EFAST) vs Cardiomo
Backers
Who funded each tool's parent company.